Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain
Interferons (IFNs) are cytokines with diverse functions, possessing antiviral, antiproliferative, and immunomodulatory effects. IFN-α and IFN-β, key members of the type I interferon (IFN-I) family, are widely used in the treatment of diseases such as hepatitis and multiple sclerosis. In the nervous...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2025-06-01
|
| Series: | Journal of Integrative Neuroscience |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/JIN/24/6/10.31083/JIN33414 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849429451456118784 |
|---|---|
| author | Ti-Chuan Chiu Yu-Yu Li Chia-Hung Yu Kuo-Chuan Hung Chin-Chen Chu Ping-Hsun Feng Ping-Heng Tan |
| author_facet | Ti-Chuan Chiu Yu-Yu Li Chia-Hung Yu Kuo-Chuan Hung Chin-Chen Chu Ping-Hsun Feng Ping-Heng Tan |
| author_sort | Ti-Chuan Chiu |
| collection | DOAJ |
| description | Interferons (IFNs) are cytokines with diverse functions, possessing antiviral, antiproliferative, and immunomodulatory effects. IFN-α and IFN-β, key members of the type I interferon (IFN-I) family, are widely used in the treatment of diseases such as hepatitis and multiple sclerosis. In the nervous system, microglia, astrocytes, and neurons express IFN-I receptors. Beyond their classical transcriptional roles, IFN-Is can suppress neuronal activity and synaptic transmission through nongenomic mechanisms, producing potent analgesic effects. However, IFN-Is are active in signaling pathways such as phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinase (MAPK), and the MAPK-interacting serine/threonine-protein kinase (MNK)-eukaryotic initiation factor 4E (eIF4E) pathway, which can sensitize peripheral nociceptors and contribute to nociceptive responses. This narrative review explores recent advances in understanding the roles of IFN-I and the cyclic-GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling cascade in acute and chronic nociceptive responses, which are increasingly recognized but remain a subject of debate. Recent studies suggest that the STING–IFN-I pathway has complex, stage-dependent effects on nociception. In the middle to late stages of the nociceptive response, this pathway can activate signal transducer and activator of transcription (STAT) signaling, as well as microglial mediated STING pathways and tumor necrosis factor (TNF) receptor-associated factor (TRAF) family member-associated nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB activator) collectively referred to as TANK. These pathways increase pro- and anti-inflammatory cytokine production, promote microglial M1 polarization, and inhibit endoplasmic reticulum-phagy (ER-phagy) in the central nervous system (CNS). These mechanisms contribute to central sensitization while modulating the analgesic effects of IFN-Is. Thus, the STING-IFN-I pathway plays a dual role in nociception, with both pro-nociceptive and analgesic effects that are dependent on the stage of the nociceptive response. Understanding the differential roles of STING–IFN-I signaling in nociceptors under physiological and pathological conditions could pave the way for the development of targeted nociceptive response management therapies. |
| format | Article |
| id | doaj-art-cec5bdb8483641ea8b069716b3c35ec9 |
| institution | Kabale University |
| issn | 0219-6352 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | IMR Press |
| record_format | Article |
| series | Journal of Integrative Neuroscience |
| spelling | doaj-art-cec5bdb8483641ea8b069716b3c35ec92025-08-20T03:28:21ZengIMR PressJournal of Integrative Neuroscience0219-63522025-06-012463341410.31083/JIN33414S0219-6352(25)00913-1Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and PainTi-Chuan Chiu0Yu-Yu Li1Chia-Hung Yu2Kuo-Chuan Hung3Chin-Chen Chu4Ping-Hsun Feng5Ping-Heng Tan6Department of Anesthesiology, Chi Mei Medical Center, 701 Tainan, Taiwan, ROCDepartment of Anesthesiology, Chi-Mei Hospital, Chiali, 722 Tainan, Taiwan, ROCDepartment of Anesthesiology, Chi Mei Medical Center, 701 Tainan, Taiwan, ROCDepartment of Anesthesiology, Chi Mei Medical Center, 701 Tainan, Taiwan, ROCDepartment of Anesthesiology, Chi Mei Medical Center, 701 Tainan, Taiwan, ROCDepartment of Anesthesiology, Chi Mei Medical Center, Liouying, 736 Tainan, Taiwan, ROCDepartment of Anesthesiology, Chi Mei Medical Center, 701 Tainan, Taiwan, ROCInterferons (IFNs) are cytokines with diverse functions, possessing antiviral, antiproliferative, and immunomodulatory effects. IFN-α and IFN-β, key members of the type I interferon (IFN-I) family, are widely used in the treatment of diseases such as hepatitis and multiple sclerosis. In the nervous system, microglia, astrocytes, and neurons express IFN-I receptors. Beyond their classical transcriptional roles, IFN-Is can suppress neuronal activity and synaptic transmission through nongenomic mechanisms, producing potent analgesic effects. However, IFN-Is are active in signaling pathways such as phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinase (MAPK), and the MAPK-interacting serine/threonine-protein kinase (MNK)-eukaryotic initiation factor 4E (eIF4E) pathway, which can sensitize peripheral nociceptors and contribute to nociceptive responses. This narrative review explores recent advances in understanding the roles of IFN-I and the cyclic-GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling cascade in acute and chronic nociceptive responses, which are increasingly recognized but remain a subject of debate. Recent studies suggest that the STING–IFN-I pathway has complex, stage-dependent effects on nociception. In the middle to late stages of the nociceptive response, this pathway can activate signal transducer and activator of transcription (STAT) signaling, as well as microglial mediated STING pathways and tumor necrosis factor (TNF) receptor-associated factor (TRAF) family member-associated nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB activator) collectively referred to as TANK. These pathways increase pro- and anti-inflammatory cytokine production, promote microglial M1 polarization, and inhibit endoplasmic reticulum-phagy (ER-phagy) in the central nervous system (CNS). These mechanisms contribute to central sensitization while modulating the analgesic effects of IFN-Is. Thus, the STING-IFN-I pathway plays a dual role in nociception, with both pro-nociceptive and analgesic effects that are dependent on the stage of the nociceptive response. Understanding the differential roles of STING–IFN-I signaling in nociceptors under physiological and pathological conditions could pave the way for the development of targeted nociceptive response management therapies.https://www.imrpress.com/journal/JIN/24/6/10.31083/JIN33414nociceptive responsetype i interferonstingifn-αifn-βtype i interferon receptor |
| spellingShingle | Ti-Chuan Chiu Yu-Yu Li Chia-Hung Yu Kuo-Chuan Hung Chin-Chen Chu Ping-Hsun Feng Ping-Heng Tan Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain Journal of Integrative Neuroscience nociceptive response type i interferon sting ifn-α ifn-β type i interferon receptor |
| title | Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain |
| title_full | Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain |
| title_fullStr | Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain |
| title_full_unstemmed | Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain |
| title_short | Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain |
| title_sort | stimulator of interferon genes sting type i interferon signaling bridging immunity and pain |
| topic | nociceptive response type i interferon sting ifn-α ifn-β type i interferon receptor |
| url | https://www.imrpress.com/journal/JIN/24/6/10.31083/JIN33414 |
| work_keys_str_mv | AT tichuanchiu stimulatorofinterferongenesstingtypeiinterferonsignalingbridgingimmunityandpain AT yuyuli stimulatorofinterferongenesstingtypeiinterferonsignalingbridgingimmunityandpain AT chiahungyu stimulatorofinterferongenesstingtypeiinterferonsignalingbridgingimmunityandpain AT kuochuanhung stimulatorofinterferongenesstingtypeiinterferonsignalingbridgingimmunityandpain AT chinchenchu stimulatorofinterferongenesstingtypeiinterferonsignalingbridgingimmunityandpain AT pinghsunfeng stimulatorofinterferongenesstingtypeiinterferonsignalingbridgingimmunityandpain AT pinghengtan stimulatorofinterferongenesstingtypeiinterferonsignalingbridgingimmunityandpain |